Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer

Fig. 1

ARID1 subunits are tightly associated with the prognosis of NSCLC. a. The prevalence of ARID1 subunits mutations in NSCLC patients according to the cBioPortal for Cancer Genomics; b. The relationship between ARID1A expression and the prognosis of NSCLC patients; c. The relationship between ARID1B expression and the prognosis of NSCLC patients

Back to article page

Molecular Medicine

ISSN: 1528-3658